P4

HD Nursing and WellnessMats Announce Strategic Partnership, Improving Comfort and Safety of Healthcare Professionals with Medical Grade Premium Standing Solutions

Retrieved on: 
Friday, March 15, 2024

“As the leader in Premium Standing Solutions and recognized for exemplary performance throughout various industries, we are thrilled to now join forces with HD Nursing and P4 to leverage our extensive experience to enhance the occupational comfort of medical and healthcare professionals,” says Daniel Bouzide, founder and president, WellnessMats. “This is a timely opportunity for healthcare leaders in virtually every healthcare setting to rethink and prioritize the well-being of their workforces and advance initiatives for employee retention -- one step at a time.”

Key Points: 
  • HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention and WellnessMats , the leader in Premium Standing Solutions, proudly announce a strategic partnership.
  • This collaboration inaugurates a new era of improved comfort, safety, fatigue and stress relief for healthcare professionals and personnel throughout hospital and health system enterprises.
  • “This initiative underscores our joint dedication to advancing patient safety and supporting healthcare professionals throughout the healthcare ecosystem,” says Dr. Amy Hester, PhD, RN, BC, FAAN, chairwoman and CEO, HD Nursing.
  • Their professional-grade construction ensures a lasting investment that contributes to a positive work environment, improving employee retention and overall well-being.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

Retrieved on: 
Thursday, February 22, 2024

PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s Next Generation Remote Patient Monitoring (RPM) device for Obstructive Sleep Apnea (OSA).

Key Points: 
  • PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s Next Generation Remote Patient Monitoring (RPM) device for Obstructive Sleep Apnea (OSA).
  • “This pilot study validation represents a step toward bringing sleep medicine into the P4 medicine era.
  • The ProSomnus® RPMO2 OSA Device enables sleep medicine to be more personalized, predictive, preventative, and participatory,” commented Len Liptak, Chief Executive Officer for ProSomnus Sleep Technologies.
  • “The results of the pilot testing hold tremendous promise for the formal validation testing, in which the ProSomnus RPMO2 OSA Device will be compared against a gold standard.”

Acer, MediaTek, and SIMO Collaborate on Always Connected Laptop: The Acer TravelMate P4 14

Retrieved on: 
Tuesday, February 20, 2024

BARCELONA, Spain, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Acer, a global leader in technology, has collaborated with MediaTek, a leading semiconductor company, and SIMO, a pioneer in mobile connectivity solutions, to introduce the new Acer TravelMate P4 141 (TMP414-53-G2/TMP414-53-G2-TCO), an Always Connected PC (ACPC) with vSIM technology built-in, designed for international travelers, remote workers, and business professionals that are always on the move.

Key Points: 
  • The Acer TravelMate P4 14, with SIMO Inside, not only ensures always-on connectivity but also enhances security, providing users with a truly global and secure computing experience.
  • "We're excited to work with MediaTek and SIMO to enhance the mobility and connectivity of the Acer TravelMate P4 14," said James Lin, General Manager, Notebooks, Acer.
  • Acer, MediaTek, and SIMO are proud to present the TravelMate P4 14 and provide users with an unparalleled experience in mobile computing.
  • Join us at the MediaTek stand, located in Hall 3, Stand 3D10 to see the new Acer TravelMate P4 14 with SIMO Inside connectivity.

AI as the Architect of Wellbeing: Welltory Harnesses Users' Wellness Data

Retrieved on: 
Friday, February 9, 2024

REDWOOD CITY, Calif., Feb. 9, 2024 /PRNewswire/ -- As wearables and apps continuously collect users' health data, the true potential for actionable insights has largely been untapped. Welltory bridges this gap with its AI-driven analysis, transforming data from 1,000+ wearables, devices, and apps into highly personalized wellness guidance. The company harnesses AI to analyze data including sleep patterns, activity levels, and heart health, to craft personalized wellness advice. It uses proprietary models for interpreting heart rate variability signals, which leads to top-notch guidance for improving health and happiness, based on your body's signals.

Key Points: 
  • Welltory bridges this gap with its AI-driven analysis, transforming data from 1,000+ wearables, devices, and apps into highly personalized wellness guidance.
  • The company harnesses AI to analyze data including sleep patterns, activity levels, and heart health, to craft personalized wellness advice.
  • Thanks to its unique market position, Welltory owns an extensive wellness dataset from years of observation, incorporating not only data from devices, but also subjective feedback, clinical surveys, and even work-related data.
  • Users who consent to Welltory's use of their collected wellness data, receive personalized wellness guidance in the familiar app or in GPT-driven Welltory AI Coach available since December 2023.

5 New Authorized Dealers Signed by AITX’s Subsidiary Robotic Assistance Devices

Retrieved on: 
Thursday, December 14, 2023

Detroit, Michigan, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the “Company”) ( OTCPK:AITX ), a global leader in AI-driven security and productivity solutions for enterprise clients along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced the signing of 5 new authorized dealers.

Key Points: 
  • Detroit, Michigan, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the “Company”) ( OTCPK:AITX ), a global leader in AI-driven security and productivity solutions for enterprise clients along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced the signing of 5 new authorized dealers.
  • IT Installs , located in Sarasota, Florida provides nationwide installation services for all types of IT and security services equipment.
  • When it comes to demonstrating RAD solutions to clients and prospects, RAD authorized dealers must obtain a demonstration unit.
  • AITX, through its subsidiary, Robotic Assistance Devices , Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model.

ONF Merges Market Leading Portfolio of Open Source Networking Projects into the Linux Foundation

Retrieved on: 
Thursday, December 14, 2023

SAN FRANCISCO, Dec. 14, 2023 /PRNewswire/ -- The Open Networking Foundation (ONF) today announced that its portfolio of leading open source networking projects, encompassing access, edge and cloud solutions, are set to graduate to become independent projects under the Linux Foundation (LF). The move creates independent, community-led governance for the three major project areas: Broadband, Aether and P4, and sets the projects up for broader collaboration and adoption. As a result of this merger, ONF will be dissolved, transferring all operations to LF.

Key Points: 
  • Organizations Seek to Broaden Adoption, Bolster Collaboration and Expedite Innovation of Broadband, Mobile and P4 Programmable Open Networking
    SAN FRANCISCO, Dec. 14, 2023 /PRNewswire/ -- The Open Networking Foundation (ONF) today announced that its portfolio of leading open source networking projects, encompassing access, edge and cloud solutions, are set to graduate to become independent projects under the Linux Foundation (LF).
  • The portfolio includes the SEBA reference design for building open broadband networks, and the VOLTHA open source project for virtualizing multi-vendor PON systems.
  • "ONF is pleased to transition our robust portfolio of open source platforms into a set of LF-hosted community-led projects," said Timon Sloane, general manager, ONF.
  • "Open Networking Foundation (ONF), with its sister organizations Open Networking Lab and Open Networking Summit, has been a driving force for open networking and innovation across the networking industry for over 13 years.

All-new 2025 Ram 1500 Ramcharger Unveiled With Class-shattering Unlimited Battery-electric Range

Retrieved on: 
Tuesday, November 7, 2023

AUBURN HILLS, Mich., Nov. 7, 2023 /PRNewswire/ --

Key Points: 
  • All-new 2025 Ram 1500 Ramcharger's battery electric vehicle technology delivers the industry's best combination of range, towing and payload
    All-new 2025 Ram 1500 Ramcharger capable of:
    663 horsepower and 615 lb.-ft. of torque
    Towing up to 14,000 lbs.
  • and payload of up to 2,625 pounds
    The all-new 2025 Ram 1500 Ramcharger debuts today with a class-shattering targeted range of up to 690 miles.
  • "With unlimited battery-electric range, the Ram 1500 Ramcharger is the pinnacle of the light-duty pickup truck segment and the ultimate electric truck," said Tim Kuniskis, Ram brand CEO – Stellantis.
  • The 2025 Ram 1500 Ramcharger features a unique blend of exterior styling that incorporates the new themes seen in the Ram 1500 gas-powered truck and the Ram 1500 REV all-electric vehicle.

Sylvia Mdunyelwa, one of South Africa's great jazz vocalists, kept music traditions alive

Retrieved on: 
Monday, August 28, 2023

Known affectionately in her home city of Cape Town as “Mama Kaap”, Mdunyelwa passed away on 25 August at the age of 74.

Key Points: 
  • Known affectionately in her home city of Cape Town as “Mama Kaap”, Mdunyelwa passed away on 25 August at the age of 74.
  • As a researcher who documents historical and current South African jazz and popular music, I believe Mdunyelwa merits recognition not only for the regard she won from fellow players, but also for her activism as a community music educator and advocate for South African jazz.

Who was Sylvia Mdunyelwa?

    • Her uncle, Aspro Sipoyo, led the close-harmony vocal group The Semitones and her sister was a jazz singer.
    • Family gatherings sounded loud with religious songs; Fitzgerald, Vaughan and another US jazz vocalist, Carmen McRae, were all regulars on the record player.
    • Singing along, the young Nce became a singer even before she had articulated the ambition to be one.
    • Tours followed, including to the Berlin Jazz Festival and to Colombia in Latin America (where she was awarded for her community work in Cape Town).

Albums

    • Mdunyelwa released two albums, the 1998 African Diva, recorded live at the National Arts Festival in Makhanda (then Grahamstown), and the 2000 studio recording Ingoma, on the international Blue Note jazz label.
    • She served on her local street committee in Langa, and composed the impassioned anthem Where are the Children Now?
    • to draw attention to the situation of Cape Town’s young people, caught in the crossfire of poverty, family insecurity and crime.

Legacy

    • But there was always a compelling subtext of respect for Xhosa culture, the isiXhosa language and that community’s musicality.
    • She created new isiXhosa lyrics for the US jazz standard Stormy Weather, which became a favourite with her audiences.
    • She left a tangible legacy in the skills of younger musicians she inspired and mentored.
    • Nevertheless, I hope she receives multiple official tributes, accompanied by concrete support to ensure her legacy as a guardian of and activist-educator about the South African jazz tradition, however belated it all may now be.

Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea

Retrieved on: 
Wednesday, August 23, 2023

PLEASANTON, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), announced updated clinical trial data, presented at the ProSleep 2023 Users Conference earlier this month. The updated data indicate that the First Line Obstructive Sleep Apnea Treatment study (FLOSAT) is on track to achieve all endpoints.

Key Points: 
  • The updated data indicate that the First Line Obstructive Sleep Apnea Treatment study (FLOSAT) is on track to achieve all endpoints.
  • FLOSAT is an ongoing, prospective, independent, head-to-head study comparing the effectiveness of precision OAT as first-line treatment versus CPAP therapy.
  • In July , ProSomnus announced plans to design a head-to-head clinical trial comparing precision OAT and HNS in treating patients with severe OSA.
  • “The updated data and analysis from FLOSAT is validation that precision oral appliance therapy with ProSomnus devices is an effective front-line treatment for moderate to severe OSA,” said Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus.

Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women

Retrieved on: 
Wednesday, June 21, 2023

SAN DIEGO, June 21, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the publication in Menopause: The Journal of The North American Menopause Society of data from a Phase 1/2 clinical trial that evaluated the safety and pharmacokinetics of DARE-HRT1. DARE-HRT1, an investigational intravaginal ring (IVR) designed to release bio-identical 17β2-estradiol (E2) and bio-identical progesterone (P4) continuously over a 28-day period as part of a hormone therapy regimen, is part of Daré’s proprietary IVR technology platform originally developed by Dr. Robert Langer from the Massachusetts Institute of Technology and Dr. William Crowley from Massachusetts General Hospital and Harvard Medical School.

Key Points: 
  • SAN DIEGO, June 21, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced the publication in Menopause: The Journal of The North American Menopause Society of data from a Phase 1/2 clinical trial that evaluated the safety and pharmacokinetics of DARE-HRT1.
  • Data from the study support continued clinical development of DARE-HRT1 for the treatment of menopausal symptoms.
  • “Guidance from the North American Menopause Socierty asserts that hormone therapy remains the most effective treatment for vasomotor symptoms.
  • Ongoing activities to support progressing directly into a single Phase 3 study to support registration include manufacturing and non-clinical studies to support the IND submission and the planned IND-opening Phase 3 study.